ALPHARETTA, Ga., Feb. 28, 2017 -- Aptean is pleased to announce their sponsorship and attendance at LogiMed US, a premier conference for medical device suppliers, taking place in Austin, Texas, March 7-9th, 2017. Aptean is a leading global provider of mission critical enterprise software solutions, including Supply Chain Management (SCM), and serves more than 6,500 customers worldwide.
LogiMed brings together some of the biggest healthcare solution providers, including medical device manufacturers and service providers, and supply chain experts. Aptean has extended its SCM reach into the healthcare sector and will focus on showcasing their top medical supply chain complimentary solutions, including:
- Catalyst Warehouse Management System (WMS)
- i-Supply Collaborative Inventory Management
- Verdiem PC Fleet Management
- irms|360 Enterprise Solutions cloud-based WMS software
“In recent years the medical supply chain industry has become significantly more complex and demanding. Aptean is committed to helping our customers solve those challenges and achieve results with our deep industry knowledge and leading supply chain solutions," said Brad Steger, Senior Vice President Process ERP and Supply Chain Management Product Group. “We are looking forward to connecting with leaders in the medical supply chain industry at LogiMed US.”
For more information, LogiMed attendees should visit booth #11 at the event to speak with Aptean’s medical supply chain experts and view demos of their Catalyst and i-Supply solutions.
To learn more about the LogiMed event or register as an attendee, please visit http://logimedusa.wbresearch.com/.
ABOUT APTEAN
Aptean is a leading global provider of mission critical enterprise software solutions. We build and acquire industry-focused solutions to support the evolving operational needs of our customers. Our solutions help nearly 6,500 organizations stay at the forefront of their industries by enabling them to operate more efficiently, thereby ensuring higher customer satisfaction. For more information, visit www.aptean.com.
Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.
FOR MORE INFORMATION Media Relations Melissa Floyd, Aptean [email protected]


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



